新华制药股价下跌1.17% 新药入场能否破解业绩困局

金融界
23 Jul

截至2025年7月22日收盘,新华制药股价报16.89元,较前一交易日下跌1.17%,成交额3.38亿元。新华制药主营业务涵盖化学原料药、制剂及医药中间体,产品包括布洛芬、阿司匹林等原料药及介宁、舒泰得等制剂。公司隶属于化学制药板块,是华鲁控股集团核心子公司。近日,新华制药宣布获得马来酸阿伐曲泊帕片的上市许可持有人资格,正式进入止血药市场。该药品适用于慢性肝病相关血小板减少症及免疫性血小板减少症...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10